3.236.221.156
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Retina

Minorities underrepresented in ophthalmology clinical trials, expected to worsen by 2050

In ophthalmology clinical trials that led to drug approvals by the U.S. Food and Drug Administration, representation by Black, Hispanic or Latinx, and other non-White participants was less than expected in relation to disease burden and racial/ethnic distribution, according to a study. Researchers used data from clinical trials of drugs...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-